Marseilles, France

Stéphanie Cornen

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovator Stéphanie Cornen: Pioneering Advances in Cancer Treatment

Introduction

Stéphanie Cornen, an accomplished inventor based in Marseilles, France, has made significant strides in the biomedical field with a portfolio of four patents. He is dedicated to developing innovative therapies aimed at treating cancer and inflammatory diseases.

Latest Patents

Stéphanie's groundbreaking inventions include:

1. **KIR3DL2 binding agents** - This invention focuses on methods for treating cancer and inflammatory diseases utilizing antibodies, such as monoclonal antibodies, that specifically bind KIR3DL2. Additionally, it encompasses the creation of antibodies, cells producing such antibodies, methods for production, and related pharmaceutical compositions.

2. **Siglec-9-neutralizing antibodies** - This invention involves agents that target human Siglecs, which inhibit immune cell activity. These agents have the potential to neutralize this inhibitory capacity, making them beneficial for treating various cancers and infectious diseases.

Career Highlights

Stéphanie Cornen is currently employed at Innate Pharma, a prominent company specializing in the development of immune-oncology therapies. Through his work, he has contributed to advancing the landscape of treatments available for patients battling complex diseases.

Collaborations

Throughout his career, Stéphanie has collaborated with esteemed colleagues, including Benjamin Rossi and Laurent Gauthier. Their teamwork and collective expertise have significantly augmented the efforts directed toward innovative treatments in the pharmaceutical industry.

Conclusion

Stéphanie Cornen's dedication to invention and innovation stands as a testament to his commitment to improving healthcare through advanced therapies. His contributions in the realm of biomedical research highlight the vital intersection of ingenuity and practical application in fighting diseases such as cancer and infections. As he continues his work at Innate Pharma, the potential impact of his inventions promises to enhance patient outcomes significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…